Prevalence of IDA in pregnancy - Idpas.org

More documents

Recommendations

Info

Weekly dosing in at least some situations?
2. Minimize Side Effects • “There is little evidence that side effects are the major cause of non-compliance” (Galloway, 1994). • Blot, Simmons, IOM 2000 • with 65 mg x 3, 25% symptoms vs 13% placebo • with 130 x 3 40% symptoms • “unlikely that 60 mg x 2 would affect compliance” IOM 1993
Page 1 and 2: Prevalence of IDA in pregnancy Lind
Page 3 and 4: Trends in the Prevalence of Anemia
Page 5 and 6: Anemia and Indicators of Iron Statu
Page 7 and 8: Anemia and Indicators of Iron Statu
Page 9 and 10: Transferrin receptors in pregnancy
Page 13 and 14: 100 mg/d Fe Improved Infant Serum F
Page 15 and 16: Iron supplementation in pregnancy r
Page 17 and 18: 100 mg/d Fe reduced % anemia in Tan
Page 19 and 20: Non-intervention Studies: Anemia an
Page 21 and 22: Recent Intervention Trial Shows Eff
Page 23 and 24: Maternal CRH in pre-term, term, & p
Page 26 and 27: Impact of birth weight on iron stat
Page 28 and 29: Guidelines for Iron Supplementation
Page 30 and 31: • Honduran infants Dewey et al. 1
Page 32 and 33: How can guidelines be improved? •
Page 34: 1. Be more specific about number of
Page 40 and 41: Unanswered Questions • How much s
Page 42 and 43: Similarities and Differences Betwee
Page 44 and 45: Normal hemoglobin values during pre
Page 46 and 47: Iron Status in Trimester I Predicts
Page 48 and 49: Attributing Mortality to Anemia is
Page 50: Conclusions from Meta-Analysis of D

Prevalence of IDA in pregnancy - Idpas.org

Create successful ePaper yourself

Delete template?

Save as template?